← All Biocardia, INC filings

Biocardia, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
BCDA
Biocardia, INC
SCHEDULE 13D: BioCardia Chairman Andrew Blank Boosts Stake to 5.5% Through Recent Private Placement
Andrew Scott Blank, Chairman of BioCardia, Inc.'s Board of Directors, has increased his beneficial ownership in the company to 5.5% following a recent private placement and other share acquisitions.
NASDAQ
BCDA
Biocardia, INC
SCHEDULE 13D/A: Joseph P. Daly Ceases to Hold Reportable Stake in BioCardia, Inc.
Joseph P. Daly has filed an amended Schedule 13D indicating he no longer beneficially owns more than 5% of BioCardia, Inc.'s common stock as of May 13, 2025.